Comment on: "Levothyrox^® New and Old Formulations: Are they Switchable for Millions of Patients?"

Joël Coste^{1

2}, Xavier Bertagna³, Mahmoud Zureik^{4

5}

Affiliations

¹ Biostatistics and Epidemiology Unit, Hôpital Cochin, 27 rue du faubourg Saint-Jacques, 75014, Paris, France. joel.coste@aphp.fr.
² Paris Descartes School of Medicine, Paris Descartes University, Paris, France. joel.coste@aphp.fr.
³ Paris Descartes School of Medicine, Paris Descartes University, Paris, France.
⁴ EPI-PHARE (GIS ANSM-CNAM), Paris, Saint-Denis, France.
⁵ Versailles Saint-Quentin University, Versailles, France.

Comment

Joël Coste et al. Clin Pharmacokinet. 2019 Jul.

. 2019 Jul;58(7):965-966.

doi: 10.1007/s40262-019-00779-9.

Joël Coste^{1

2}, Xavier Bertagna³, Mahmoud Zureik^{4

5}

¹ Biostatistics and Epidemiology Unit, Hôpital Cochin, 27 rue du faubourg Saint-Jacques, 75014, Paris, France. joel.coste@aphp.fr.
² Paris Descartes School of Medicine, Paris Descartes University, Paris, France. joel.coste@aphp.fr.
³ Paris Descartes School of Medicine, Paris Descartes University, Paris, France.
⁴ EPI-PHARE (GIS ANSM-CNAM), Paris, Saint-Denis, France.
⁵ Versailles Saint-Quentin University, Versailles, France.

No abstract available

Comment in

Authors' Reply to Coste et al.: "Levothyrox^® New and Old Formulations: Are they Switchable for Millions of Patients?".
Concordet D, Gandia P, Montastruc JL, Bousquet-Mélou A, Lees P, Ferran AA, Toutain PL. Concordet D, et al. Clin Pharmacokinet. 2019 Jul;58(7):967-968. doi: 10.1007/s40262-019-00780-2. Clin Pharmacokinet. 2019. PMID: 31161455 Free PMC article. No abstract available.

Levothyrox^® New and Old Formulations: Are they Switchable for Millions of Patients?
Concordet D, Gandia P, Montastruc JL, Bousquet-Mélou A, Lees P, Ferran A, Toutain PL. Concordet D, et al. Clin Pharmacokinet. 2019 Jul;58(7):827-833. doi: 10.1007/s40262-019-00747-3. Clin Pharmacokinet. 2019. PMID: 30949873 Free PMC article.

1. Concordet D, Gandia P, Montastruc JL, Bousquet-Mélou A, Lees P, Ferran A, et al. Levothyrox^® new and old formulations: are they switchable for millions of patients? Clin Pharmacokinet. 2019. https://doi.org/10.1007/s40262-019-00747-3 . - DOI - PubMed - PMC
1. Cox C. Delta method. In: Gail MH, Benichou J, editors. Encyclopedia of biostatistics. New York: Wiley; 1998. p. 1125–7.
1. Les jours. “Levothyrox: une étude confirme le laxisme de Merck et de l’ANSM”. 2019. https://lesjours.fr/obsessions/levothyrox/ep20-etude-laxisme-ansm . Accessed 13 Apr 2019.
1. Le Monde. “Levothyrox: l’étude qui donne raison aux patients”. 2019. https://www.lemonde.fr/sciences/article/2019/04/04/levothyrox-une-etude-... . Accessed 13 Apr 2019.
1. Politique.org, “Scandale du Levothyrox: l’étude qui donne raison aux patients”. 2019. http://www.politique.org/blog/2019/04/09/scandale-du-levothyrox-letude-q... . Accessed 13 Apr 2019.